Loading clinical trials...
Loading clinical trials...
The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine Tablets, 5 mg, to SALAGEN® Tablets, 5 mg (MGI Pharma) under fed conditions using a single-dose, 2-treatment, 2-...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Roxane Laboratories
NCT05964959 · Xerostomia, End of Life, and more
NCT06708195 · Xerostomia, Dry Mouth
NCT06412627 · Endotracheal Tube, Thirst, and more
NCT05871580 · Burning Mouth Syndrome, Quality of Life, and more
NCT06258603 · Pneumonia, Mechanical Ventilation Complication, and more
CEDRA Clinical Research, LLC
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions